当前位置:首页 - 行情中心 - 药明康德(603259) - 财务分析

药明康德

(603259)

  

流通市值:2622.67亿  总市值:3163.98亿
流通股本:24.73亿   总股本:29.84亿

药明康德(603259)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润122.06亿元,每股收益4.25元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益7147249.73万元,未分配利润3912934.81万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产9460613.54万元,负债2313363.81万元。

利润表
报告期2025-09-302025-06-302025-03-312024-12-31
营业总收入32,856,716,508.8620,799,281,882.469,654,595,304.2839,241,431,359.88
营业总成本21,256,267,707.6714,014,556,298.926,712,128,987.7227,342,268,206.88
其他经营收益
营业利润15,066,061,792.999,931,118,357.54,292,748,775.2911,580,174,718.14
利润总额15,037,068,350.449,907,416,557.974,279,893,550.8811,539,811,639.08
净利润12,206,193,461.268,660,348,120.543,715,468,841.049,567,739,539.18
每股收益
其他综合收益-95,953,157.33-37,885,690.49118,473,436.43185,718,884.52
综合收益总额12,110,240,303.938,622,462,430.053,833,942,277.479,753,458,423.7
资产负债表
报告期2025-09-302025-06-302025-03-312024-12-31
流动资产:
流动资产合计53,812,305,105.1242,588,730,423.9943,308,063,148.9438,690,152,263.99
非流动资产:
非流动资产合计40,793,830,310.9541,235,049,478.2541,204,024,944.2941,635,672,144.76
资产总计94,606,135,416.0783,823,779,902.2484,512,088,093.2380,325,824,408.75
流动负债:
流动负债合计19,438,255,302.4720,518,915,049.3418,873,805,072.3216,226,114,890.7
非流动负债:
非流动负债合计3,695,382,808.92,895,783,098.12,859,521,263.65,014,095,882.48
负债合计23,133,638,111.3723,414,698,147.4421,733,326,335.9221,240,210,773.18
所有者权益(或股东权益):
归属于母公司股东权益合计70,948,120,408.1759,911,708,305.0362,332,382,757.1158,632,715,174.37
股东权益合计71,472,497,304.760,409,081,754.862,778,761,757.3159,085,613,635.57
负债和股东权益合计94,606,135,416.0783,823,779,902.2484,512,088,093.2380,325,824,408.75
现金流量表
报告期2025-09-302025-06-302025-03-312024-12-31
经营活动产生的现金流量:
经营活动现金流入小计36,111,478,614.8724,056,009,009.6511,640,339,447.6943,465,208,735.14
经营活动现金流出小计24,698,643,947.416,625,027,477.958,444,909,585.9731,058,693,900.55
经营活动产生的现金流量净额11,412,834,667.477,430,981,531.73,195,429,861.7212,406,514,834.59
投资活动产生的现金流量:
投资活动现金流入小计12,754,865,895.918,170,088,313.924,078,846,761.7111,987,982,568.26
投资活动现金流出小计12,349,902,224.226,360,546,680.631,879,090,566.0417,506,159,695.01
投资活动产生的现金流量净额404,963,671.691,809,541,633.292,199,756,195.67-5,518,177,126.75
筹资活动产生的现金流量:
筹资活动现金流入小计18,571,573,684.897,677,208,916.664,767,126,048.911,986,352,535.19
筹资活动现金流出小计18,148,916,382.2112,606,536,226.073,531,089,417.3515,818,543,183.22
筹资活动产生的现金流量净额422,657,302.68-4,929,327,309.411,236,036,631.55-3,832,190,648.03
汇率变动对现金及现金等价物的影响-209,209,966.1-203,423,250.66-61,078,422.61387,525,345.81
现金及现金等价物净增加额12,031,245,675.744,107,772,604.926,570,144,266.333,443,672,405.62
期末现金及现金等价物余额25,475,956,893.3817,552,483,822.5620,014,855,483.9713,444,711,217.64
补充资料:
现金及现金等价物的净增加额-4,107,772,604.92-3,443,672,405.62
最新报告期:2025-10-28
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
招银国际JillWu,BenchenHuang------2025-10-28
信达证券唐爱金5.004.725.452025-10-27
招商证券梁广楷,许菲菲4.685.546.732025-10-27
浦银国际证券阳景,胡泽宇4.855.566.352025-10-27
中国银河程培5.605.486.662025-10-27
TOP↑